PITTSBURGH The Food and Drug Administration has approved two generic drugs by Mylan for treating hypertension, Mylan said Friday. The company announced the approval of losartan potassium and ...

Vivimed Life Sciences has issued a voluntary recall of its losartan potassium tablets after the impurity N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) was detected. It’s used to treat high blood ...

A pharmaceutical company is expanding its recall of certain blood pressure medication tablets after trace amounts of a possible cancer causing impurity were discovered in the active ingredient, the ...

PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals USA, Inc. has initiated a voluntary recall in the United States, to the patient level, of 35 lots of bulk Losartan Potassium USP Tablets (6 lots ...

Torrent Pharmaceuticals Limited has increased the company’s recent recall of Losartan potassium tablets USP from two lots to 10 lots. The drugs have a trace amount of an unexpected impurity called ...

Torrent Pharmaceuticals Limited is voluntarily recalling 60 lots of Losartan potassium tablets USP and 54 lots of Losartan potassium/ hydrochlorothiazide tablets, USP, to the consumer level due to the ...

(KPLC) - Two more hypertension medications have been recalled due to a possible process impurity or contaminant in an active pharmaceutical ingredient, according to the FDA. Legacy Pharmaceutical ...

Arbli is supplied as an peppermint-flavored oral suspension containing 10mg/mL of losartan potassium in 165mL bottles. The Food and Drug Administration (FDA) has approved Arbli ™, an oral suspension ...

Torrent Pharmaceuticals Limited has again expanded a recall of its blood pressure medication over concerns the tablets contain small amounts of a cancer-causing ingredient. In a Sept. 19 statement, ...